Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Nov 11;105(45):17379-83.
doi: 10.1073/pnas.0807764105. Epub 2008 Nov 5.

Structure of transmembrane pore induced by Bax-derived peptide: evidence for lipidic pores

Affiliations

Structure of transmembrane pore induced by Bax-derived peptide: evidence for lipidic pores

Shuo Qian et al. Proc Natl Acad Sci U S A. .

Abstract

The structures of transmembrane pores formed by a large family of pore-forming proteins and peptides are unknown. These proteins, whose secondary structures are predominantly alpha-helical segments, and many peptides form pores in membranes without a crystallizable protein assembly, contrary to the family of beta-pore-forming proteins, which form crystallizable beta-barrel pores. Nevertheless, a protein-induced pore in membranes is commonly assumed to be a protein channel. Here, we show a type of peptide-induced pore that is not framed by a peptide structure. Peptide-induced pores in multiple bilayers were long-range correlated into a periodically ordered lattice and analyzed by X-ray diffraction. We found the pores induced by Bax-derived helical peptides were at least partially framed by a lipid monolayer. Evidence suggests that the formation of such lipidic pores is a major mechanism for alpha-pore-forming proteins, including apoptosis-regulator Bax.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig. 1.
Fig. 1.
Two models of peptide-induced pores in membranes and the experimental proof for each. (A and B) Schematics of the barrel-stave model (A) and the toroidal model (B) are shown in a 3D view cut through the pores, showing only the layers representing the lipid headgroups (silver) and the Br atoms (red). Blue-gray cylinders represent peptide segments; the actual distribution and orientation of peptides are expected to vary with peptide and lipid. Schematic lipid molecules [1,2-distearoyl(9–10dibromo)-sn-glycero-3-phosphocholine] are shown in A, where the red dots represent the Br atoms on the chains. (C and D) The normalized electron density distributions of Br atoms in a unit cell of the R phase containing alamethicin and Bax-α5, respectively. (The data for C were reproduced from ref. .) Br atoms are distributed in the high-density (yellow-red-black) region. The nonuniformity in the low-density region (light blue to dark blue, which average to ≈0 e/Å3) is due to the limited resolution (28).
Fig. 2.
Fig. 2.
Grazing-angle diffraction pattern from the R phase of a Bax-α5 and di18:0(9,10Br)PC mixture in the molar ratio of 1:30 at 60% RH, 25 °C. The vertical (qz) is normal to the substrate. To show all peaks clearly, intensity attenuators were applied to the peaks on qz and on the 2 columns next to qz.
Fig. 3.
Fig. 3.
Multiwavelength anomalous diffraction analyses for the detected peaks. For each independent peak, the square root of the integrated intensity, ∣Fλ∣, is plotted as a function of ∣f′λ∣/fn. The data are fit with a straight line, from which ∣F0∣, ∣F2∣, and the ratio ∣F0∣/∣F2∣ are obtained. The results are in Table 1.
Fig. 4.
Fig. 4.
Three-dimensional swelling method for phase determination applied to the rhombohedral phase (42). Shown is the swelling method applied to different qr series using the diffraction amplitudes obtained at 50% RH (open circles) and 60% RH (filled circles). (A) qr = 0 nm−1 series. (B) qr = 1.11 nm−1 series. (C) qr = 1.92 nm−1 series. The vertical scales are relative. The solid curves are F(qH,K,qz) of equation 12 in ref. constructed from 1 set of data measured at 1 relative humidity (see details in ref. 42).

References

    1. Panchal RG, Smart ML, Bowser DN, Williams DA, Petrou S. Pore-forming proteins and their application in biotechnology. Curr Pharm Biotechnol. 2002;3:99–115. - PubMed
    1. Heuck AP, Tweten R K, Johnson AE. Beta-barrel pore-forming toxins: Intriguing dimorphic proteins. Biochemistry. 2001;40:9065–73. - PubMed
    1. Menestrina G, Serra MD, Lazarovici P. Pore-forming Peptides and Protein Toxins. London: Taylor & Francis; 2003. pp. 1–315.
    1. van der Goot FG. Current Topics in Microbiology and Immunology. Vol 257. Berlin: Springer; 2001. Pore-forming toxins; pp. 1–166.
    1. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature. 2002;415:389–95. - PubMed

Publication types

MeSH terms